Ayumi Takaki¹, Rie Furuta¹, Naofumi Matsuno³, Shikiko Ueno¹, Tatsuya Kawaguchi¹, Masao Matsuoka¹, Yuji Yonemura² (1.Department of Hematolgy / Rheumatology / Infectious Disease, Kumamoto Univ., Kumamoto, Japan, 2.Dept. Transfusion Medicine and Cell Therapy, Kumamoto Univ., Kumamoto, Japan, 3.Hematol., Tamana Central Hospital, Kumamoto, Japan)

Yoshifumi Shimizu¹, Norimitsu Tanaka¹, Takehito Imado¹, Ako Mori¹, Tadanobu Hatsu², Naoto Takase² (1.Department of Hematology, Takarazuka City Hospital, Takarazuka, Hyogo, Japan, 2.Department of Medical Oncology, Takarazuka City Hospital, Takarazuka, Hyogo, Japan)

Takayuki Ikezoe¹, John Peipert², Austin Kulesekararaj³, Ataulfo Fernandez⁴, Susan Yount², Christa Martens², Amy Sparling², Kimberly Webster², David Cella², Scott Rottinghaus⁵, Bonnie Donato⁵, Ioannis Tomazos⁵, Anna Gaya⁶, Lindsay Mitchell⁷, Anita Hill⁸, Richard Wells⁹, Caroline Piatek¹⁰, Philip Kuriakose¹¹, Irina Murakhovskaya¹², Samer Khaled¹³, Karen Kaiser² (1.Fukushima Medical University, 2.Northwestern University Feinberg School of Medicine, Chicago, USA, 3.Kings College Hospital, London, UK, 4.Hospital Universitario Clinico San Carlos, Spain, 5.Alexion Pharmaceuticals, Inc., New Haven, USA, 6.Hospital Clinic de Barcelona, Spain, 7.University Hospital Monklands, Lanarkshire, Scotland, 8.St James Institute of Oncology, Leeds, UK, 9.Sunnybrook Health Sciences Centre, Toronto, ON, Canada, 10.University of Southern California, Los Angeles, USA, 11.Henry Ford Hospital, Detroit, USA, 12.Montefiore Medical Center, NY, USA, 13.City of Hope, Duarte, USA)

Atsushi Takahata¹, Kana Bando¹, Saeko Sonokawa¹, Shinya Ishida¹, Takuji Nakamura², Takeji Shimizu², Toyomi Kamesaki³, Koh Yamamoto¹ (1.Department of Hematology, Yokohama City Minato Red Cross Hospital, 2.Division of Clinical Laboratory, Yokohama City Minato Red Cross Hospital, 3.Center for Community Medicine, Jichi Medical University)

Mikoto Tanabe¹, Noriharu Nakagawa¹, Kohei Hosokawa¹, Thinguyen Maianh¹, Espinoza Luis¹, Kana Maruyama¹, Takamasa Katagiri¹, Hirohito Yamazaki², Shinji Nakao¹ (1.Department of Hematology, Kanazawa University, Kanazawa, Japan, 2.Department of Blood Transfusion, Kanazawa University, Kanazawa, Japan)

Junpei Rikitake¹, Kaori Shirahama², Mari Nakagawa², Hiromichi Tomita², Toshiko Yoshida², Kazuhiro Teramura³, Shigeo Hara⁴, Kazuyoshi Kajimoto⁵, Yoshitake Hayashi⁶ (1.Hematology, Yodogawa Christian Hospital, Osaka, Japan, 2.Nephrology, Yodogawa Christian Hospital, Osaka, Japan, 3.Pathology, Yodogawa Christian Hospital, Osaka, Japan, 4.Pathology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan, 5.Pathology, Hyogo Cancer Center, Hyogo, Akashi, Japan, 6.Dept. Pathology, Mol. Med. Genet., Kobe Univ., Kobe, Japan)

Jing Li¹, Long Chen¹, Qin Li² (1.SINO-US Diagnostics, Tianjin, Tianjin, People's Republic of China, 2.Institution of Hematology, Chinese Academy of Medical Sciences, Tianjin, Tianjin, People's Republic of China)